STLNW — Starling Oncology, Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1799191 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 161,282,000 193,063,000 -4,616,000 -9,789,000 178,233,000 — 203,147,000
Mar 2026 147,441,000 180,571,000 -6,513,000 -2,492,000 168,230,000 — 184,515,000
Sep 2025 136,564,000 163,538,000 -8,054,000 -16,504,000 163,619,000 — 175,893,000
Jun 2025 119,802,000 148,514,000 -11,211,000 -17,009,000 159,798,000 — 168,783,000

Yahoo Snapshot (yfinance, live)

Total Revenue
$620,446,976
EBITDA
$-14,410,000
Free Cash Flow
$29,539,624
Enterprise Value
—
Total Cash
$36,895,000
Total Debt
$102,755,000
Shares Out
—
Trailing EPS
—
Book Value
$-0.37
ROE
—
ROA
-7.5%
Div Yield
—

Annual Trend (SEC EDGAR, last 6y)

Revenues vs Net Income (last 6y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 502,729,000 -36,083,000 -60,606,000 164,656,000 180,376,000 -15,720,000 —
Dec 2024 393,412,000 -60,118,000 -64,663,000 172,717,000 169,128,000 3,589,000 —
Dec 2023 324,239,000 -77,018,000 -83,068,000 209,240,000 152,215,000 57,025,000 —
Dec 2022 252,483,000 -81,951,000 152,000 261,665,000 138,490,000 123,175,000 —
Dec 2021 203,003,000 -45,858,000 -10,927,000 203,439,000 99,280,000 104,159,000 —
Dec 2020 254,149 -683,869 -441,154 231,323,610 6,567,550 224,756,060 —

TTM Snapshot

Revenues TTM
$587,244,000
NetIncome TTM
$-36,293,000
OpCashFlow TTM
—
Assets (Latest)
$178,233,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
HCA HCA Healthcare, Inc. $104.69B $501.19 —
NTRA Natera, Inc. $41.68B $287.47 —
LH LABCORP HOLDINGS INC. $29.90B $368.24 —
DGX QUEST DIAGNOSTICS INC $28.29B $256.35 —
THC TENET HEALTHCARE CORP $22.45B $282.07 —

News headlines (Yahoo Finance, 1h cache)

Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
2026-08-17 12:00 · Yahoo
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
2026-08-06 20:14 · Yahoo
Oncology Institute Q3 Earnings Call Highlights
2026-11-06 14:14 · Yahoo
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates
2026-11-05 21:45 · Yahoo
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
2026-11-05 21:06 · Yahoo
Geron (GERN) Reports Break-Even Earnings for Q3
2026-11-04 12:55 · Yahoo
Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates
2026-11-03 21:50 · Yahoo
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
2026-10-26 13:00 · Yahoo
Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views
2026-10-15 23:22 · Yahoo
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
2026-10-01 20:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.